Showing results (361-370 of 625) with videos related to

Sort By:
Pageof 63
Physical Review Letters|December 3, 2021
Structure of a Perturbed Magnetic Reconnection Electron Diffusion Region in the Earth's MagnetotailG Cozzani, Yu V Khotyaintsev, D B Graham, et al.
The Journal of Physiology|March 18, 2006
Novel role of 26RFa, a hypothalamic RFamide orexigenic peptide, as putative regulator of the gonadotropic axisV M Navarro, R Fernández-Fernández, R Nogueiras, et al.
The Review of Scientific Instruments|April 8, 2010
Electronic temperatures, densities, and plasma x-ray emission of a 14.5 GHz electron-cyclotron resonance ion sourceA Gumberidze, M Trassinelli, N Adrouche, et al.
Nature Genetics|June 3, 2000
Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticumO Le Saux, Z Urban, C Tschuch, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2015
Impact of ceftiofur injection on gut microbiota and Escherichia coli resistance in pigsM A Fleury, G Mourand, E Jouy, et al.
BMC Pulmonary Medicine|May 18, 2019
Prevalence and management of chronic breathlessness in COPD in a tertiary care centerH Carette, M Zysman, C Morelot-Panzini, et al.
Endoscopy|March 13, 2009
Appropriateness of colonoscopy in Europe (EPAGE II). Iron-deficiency anemia and hematocheziaI Peytremann-Bridevaux, C Arditi, F Froehlich, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 29, 2014
Disseminated arterial calcification and enhanced myogenic response are associated with abcc6 deficiency in a mouse model of pseudoxanthoma elasticumGilles Kauffenstein, A Pizard, Y Le Corre, et al.
Journal of Medicinal Chemistry|October 10, 1998
Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogensC Agouridas, A Denis, J M Auger, et al.
ESMO Open|June 5, 2025
Tumor-stroma proportion on primary tumor as a prognostic biomarker in advanced ovarian cancer patients receiving chemo-immunotherapy as first-line therapy: analyses from the NeoPembrOV/GINECO phase II randomized trialL Collet, J-C Noël, X Catteau, et al.
Pageof 63